Prospective molecular marker analyses of EGFR and KRAS from a randomized, placebo-controlled study of erlotinib maintenance therapy in advanced non-small-cell lung cancer (Q44846520)
Jump to navigation
Jump to search
scientific article published on 3 October 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prospective molecular marker analyses of EGFR and KRAS from a randomized, placebo-controlled study of erlotinib maintenance therapy in advanced non-small-cell lung cancer |
scientific article published on 3 October 2011 |
Statements
1 reference
Prospective molecular marker analyses of EGFR and KRAS from a randomized, placebo-controlled study of erlotinib maintenance therapy in advanced non-small-cell lung cancer (English)
1 reference
1 reference
Raimundas Sakalauskas
1 reference
Wolfram Brugger
1 reference
Nadja Triller
1 reference
Maria Blasinska-Morawiec
1 reference
Stefan Curescu
1 reference
Georgy Moiseevich Manikhas
1 reference
Renaud Whittom
1 reference
Carol Ward
1 reference
Karen Mayne
1 reference
Kerstin Trunzer
1 reference
3 October 2011
1 reference
1 reference
29
1 reference
31
1 reference
4113-4120
1 reference
Identifiers
1 reference
1 reference